No.

Publication Date

Citing Article

1

2025

Pornthip Waiwut, Pitchayakarn Takomthong, Rutchayaporn Anorach, Nattareeyada Lomaboot, Supawadee Daodee, Yaowared Chulikhit, Orawan Monthakantirat, Charinya Khamphukdee, Chantana Boonyarat. Pharmacological Evaluation of a Traditional Thai Polyherbal Formula for Alzheimer’s Disease: Evidence from In Vitro and In Silico Studies, International Journal of Molecular Sciences. 2025; 26: 6287.  https://doi.org/10.3390/ijms26136287

2

2026

Andrey V Kuznetsov, Predicting biological age using an accumulated neurotoxicity biomarker for amyloid beta oligomers, Mathematical Medicine and Biology: A Journal of the IMA. 2026; dqag005.  https://doi.org/10.1093/imammb/dqag005

3

2026

Dileep Kumar, Vinayak Walhekar, K. Mangala Shenoy, Suvarna G. Kini. In silico investigation of thiazole–semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer’s disease, Scientific Reports. 2026; 16: 25231.  https://doi.org/10.1038/s41598-026-55932-9

4

2025

Karin Ben Zaken, Samuel Mesfin, Naamah Bloch, Abraham O Samson. Virtual screening of drugs against multiple targets of Alzheimer's disease, Journal of Alzheimer’s Disease. 2025; 108: 1088.  https://doi.org/10.1177/13872877251387167

5

2026

Alexandros Kordatzakis, Margaux Kourkouliotis, Andriana Hadjiyianni, Emma Arifagic, Eleni Paradeisi, Datis Kalali. The role of glutathione peroxidase enzymes in Alzheimer's disease, European Journal of Clinical and Experimental Medicine. 2026; 24:   https://doi.org/10.15584/ejcem.2026.2.4

6

2025

Pallavi Gangarde, Shvetank Bhatt, Rohini Pujari. Assessment of neuroprotective potential of Cuscuta reflexa in aluminium chloride-induced experimental model of Alzheimer’s disease: In vitro and in vivo studies, Journal of Trace Elements in Medicine and Biology. 2025; 88: 127612127612.  https://doi.org/10.1016/j.jtemb.2025.127612

7

2025

Andrey V. Kuznetsov, 2025;   https://doi.org/10.1101/2025.02.28.640920

8

2026

, Synthesis, ADME, and Molecular Docking Studies of Benzothiazole-Derived Oxadiazole-Based Schiff Bases as Anti-Alzheimer’s Agents, Journal of Molecular Structure. 2026; 147343147343.  https://doi.org/10.1016/j.molstruc.2026.147343

9

2026

Zufika Qamar, Saif Ahmad Khan, Pallavi Kumari, Mariya Khan, Pushadapu Veera Venkata Siva Krishna, Shweta Dang, Sanjula Baboota, Asgar Ali, Javed Ali. Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma, Expert Opinion on Drug Delivery. 2026; 23: 247.  https://doi.org/10.1080/17425247.2025.2578384

10

2025

Saif Ahmad Khan, Zufika Qamar, Aashish Rohilla, Pirthi Pal Singh, Suhel Parvez, Sanjula Baboota, Javed Ali. Prospective Utilization of Nanocarriers Loaded with Drug Combination for Treating Alzheimer's Disease, Current Pharmaceutical Design. 2025; 31: 1444.  https://doi.org/10.2174/0113816128348877241202053633

11

2026

Amandeep Thakur, Mandeep Rana, Sakshi Vanjani, Kei‐Chi Liou, Rajeev Taliyan, Kunal Nepali, Chih‐Hao Yang. Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns, Medicinal Research Reviews. 2026; 46: 1173.  https://doi.org/10.1002/med.70047

12

2026

Danqing Xiao, Akshita Duvvuri, Lenna V. Makrigiannis, Catherine Fuller. The Neuroprotective Role of Exercise in Alzheimer’s Disease: An Integrative Review of Animal and Human Studies, Neurology International. 2026; 18: 113.  https://doi.org/10.3390/neurolint18060113

13

2026

Shalini Raghuvanshi, Avijit Mazumder, Saumya Das. Targeting Microglial Phagocytosis for Alzheimer's Disease Management: Natural, Pharmacological, Nanoparticle, and Gene Therapy Approaches, CNS & Neurological Disorders - Drug Targets. 2026; 25: 1.  https://doi.org/10.2174/0118715273378092250623064748

14

2026

William Z. Suo, Targeting Intrinsic Neuronal Defense Against Multiple Insults: The “One4More” Therapeutic Strategy for Alzheimer’s Disease, Neuropharmacology and Therapy. 2026; 3:   https://doi.org/10.15212/npt-2025-0012

15

2026

Rashmi Madhariya, Vikas Kumar, Prince Nikhil Rathore, Alpana Ram. 2026; 521.  https://doi.org/10.1002/9781394336241.ch16

16

2025

William G. Ryan, Hunter M. Eby, Nicole R. Bearss, Ali S. Imami, Abdul-rizaq Hamoud, Priyanka Pulvender, Justin L. Bollinger, Eric S. Wohleb, Robert E. McCullumsmith. 2025;   https://doi.org/10.1101/2025.04.18.649617

17

2026

Subashchandrabose Chinnathambi, Nagaraj Rangappa. 2026; 151: 157.  https://doi.org/10.1016/bs.apcsb.2025.10.014

18

2026

Pragati A. Dongare, Deepak Khobragade, Surendra Agrawal, Mrunali Potbhare. 2026; 185.  https://doi.org/10.1002/9781394336241.ch6

19

2026

Noor Muhammad, Rui Ai, Limin Yang, Yuelong Cui, Liqiang Wang, Shaoting Weng, Yao Wang, Mohib Ullah Kakar, Suliman Khan, Sajjad Ahmad, Imran Iqbal. Emerging neuroprotective mechanisms and therapeutic potential of natural polysaccharides in Alzheimer's disease, Frontiers in Aging Neuroscience. 2026; 18: 1877358.  https://doi.org/10.3389/fnagi.2026.1877358

20

2025

Ryszard Pluta, Editorial: Alzheimer’s disease, Exploration of Neuroscience. 2025; 4: 100694.  https://doi.org/10.37349/en.2025.100694

21

2026

Pradip S. More, Shyam W. Rangari, Swati N. Lade, Diksha S. Unidrwade, Sushil S. Burle, Milind J. Umekar, Radheshyam T. Lohiya, Aarti S. Zanwar. Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates, Ageing Research Reviews. 2026; 118: 103113103113.  https://doi.org/10.1016/j.arr.2026.103113

22

2025

Dar Junaid Bashir, Khursheed Ahmad Bhat, Masarat Bashir. Deciphering Alzheimer’s disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier, Brain Research. 2025; 1863: 149828149828.  https://doi.org/10.1016/j.brainres.2025.149828

23

2026

Asma Sardar, Rafaqat Hussain, Shoaib Khan, Tayyiaba Iqbal, Hina Sarfraz, Ayaz Ali Khan, Ammena Y. Binsaleh, Nawal Al-Hoshani, Maher S. Alwethaynani, Nuha Anajirih, Fakhria A. Al-Joufi. In Vitro Biological Screening and In Silico Molecular Modeling Studies of Thiadiazole-Bearing Benzoxazole Derivatives as Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors, Journal of Computational Biophysics and Chemistry. 2026; 25: 1497.  https://doi.org/10.1142/S2737416525501042

24

2026

Showkat Ul Nabi, Iyman Rasool, Andleeb Khan, Abrar Ul Haq, Iqra Hussain, Mosin Saleem Khan, Sabhiya Majid, Summya Rashid, Shahzada Mudasir Rashid, Nouroz Sehar, Mashoque Ahmad Rather, Muneeb U. Rehman. Peptide-based therapeutics in the management of Alzheimer’s disease (AD) and their potential to develop novel strategies, Metabolic Brain Disease. 2026; 41: 78.  https://doi.org/10.1007/s11011-025-01781-w

25

2026

Arvind Kumar Patel, Manish Singh, Shivam Kumar, Shankul Kumar, Neha Singh, Neetu Sachan, Phool Chandra. 2026; 282.  https://doi.org/10.2174/9798898814953126010013

26

2024

Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, Dania Thaher, Weam Jaghama, Donia Karaman, Rafik Karaman. Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease, Molecules. 2024; 29: 5131.  https://doi.org/10.3390/molecules29215131

27

2026

Moataz A. Shaldam, Marwa Balaha, Haytham O. Tawfik, Paolo Guglielmi, Francesca Diomede, Wagdy M. Eldehna. 2026; 351.  https://doi.org/10.1016/B978-0-443-43812-7.00001-0

28

2026

Mansi Verma, Niraj Kumar Singh. From bench to bedside: Emerging therapeutics for alzheimer's disease in clinical trials, Metabolic Brain Disease. 2026; 41: 59.  https://doi.org/10.1007/s11011-026-01793-0

29

2025

Betül Kaya, Ulviye Acar Çevik, Bilge Çiftçi, Adem Necip, Mesut IŞIK, Ebru Nur Ay, Süleyman Yur, Yusuf Özkay, Şükrü Beydemir, Zafer Asım Kaplancıklı. Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer’s Disease, ACS Omega. 2025; 10: 38427.  https://doi.org/10.1021/acsomega.5c01055